| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Sep―10 |
Retinal vascular occlusion after COVID-19 vaccination: analysis of the French pharmacovigilance database |
Mathilde Beurrier, Jean-Bapiste Conart, Marie Lauren Antoine, Anthony Facile, Haleh Bagheri, Valérie Gras-Champel, Nadine Petitpain |
| 2 |
[GO] |
2024―Jun―21 |
COVACPREG, a French prospective cohort study of women vaccinated against Covid-19 during pregnancy |
Isabelle Lacroix, Anthony Caillet, Laurane Delteil, Hadjer Ameur, Nassima Padelli, Caroline Hurault-Delarue, Judith Cottin |
| 3 |
[GO] |
2024―Mar―28 |
Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: a competition bias study from case/non case analysis |
Francis Adjaï, Dorine Fournier, Charles Dolladille, Bénédicte Lebrun-Vignes, Kevin Bihan |
| 4 |
[GO] |
2024―Jan―26 |
Chronic spontaneous urticaria after COVID-19 vaccination |
Öner Özdemir |
| 5 |
[GO] |
2024―Jan―26 |
Response to Letter about « Chronic spontaneous urticaria after COVID-19 vaccination » |
Ahmed Zaiem |
| 6 |
[GO] |
2024―Jan―21 |
Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions |
François Montastruc, Fabrice Muscari, Ivan Tack, Justine Benevent, Margaux Lafaurie, Claire de Canecaude, Haleh Bagheri, Fabien Despas, Christine Damase-Michel, Geneviève Durrieu, Agnès Sommet |
| 7 |
[GO] |
2024―Jan―17 |
Chronologie de la certification ISO 9001:2015 et enquête de satisfaction au sein du centre d’investigations cliniques plurithématique (CIC-P) de l’historique hôpital Saint-Louis en période de pandémie du COVID-19 |
Zineb Ghrieb, Anouk Walter-Petrich, Jin Huang, Sylvie Chevret, Claire Montlahuc, Matthieu Resche-Rigon, Jean-Jacques Kiladjian, Souhil Allaoua, Nabil Abdeljalil |
| 8 |
[GO] |
2023―Aug―30 |
Autoimmune hepatitis following mRNA COVID-19 vaccine* |
Ahmed Zaiem, Khouloud Ferchichi, Ghozlane Lakhoua, Widd Kaabi, Imen Aouinti, Sana Rebii Debbiche, Sarrah Kastalli, Lamia Kallel, Ons Charfi, Sihem EL Aidli |
| 9 |
[GO] |
2023―Jun―15 |
Augmentation des surdoses et décès en lien avec la consommation de méthadone durant la crise sanitaire liée au COVID-19 en 2020 |
Elisabeth Frauger, Nathalie Fouilhé, Clémence Lacroix, Amélie Daveluy, Reynald Le Boisselier, Célian Bertin, Bruno Revol, Louise Carton, Cécile Chevalier, Céline Eiden, Valérie Gibaja, Aurélie Aquizerate, Leila Chaouachi, Emilie Bouquet, Anne Roussin, Michel Mallaret, Joëlle Micallef |
| 10 |
[GO] |
2023―Jun―07 |
Acute angle closure glaucoma following COVID-19 vaccination* |
Yasmine Salem Mahjoubi, Israa Dahmani, Ines Souilem, Imen Aouinti, Sarrah Kastalli, Riadh daghfous, Sihem El Aidli |
| 11 |
[GO] |
2023―Jun―07 |
Hydroxychloroquine and COVID-19: the endgame! |
Dominique Deplanque |
| 12 |
[GO] |
2023―Jun―02 |
Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted? |
Damien Barraud, Lonni Besancon, Elisabeth M Bik, Eric Billy, Franck Clarot, Fabrice Frank, Anthony Guihur, David Hajage, Karine Lacombe, Hervé Maisonneuve, Mathieu Molimard, Matthieu Mulot, Alexander Samuel |
| 13 |
[GO] |
2023―May―25 |
Response to Letter “Only blames SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out” |
Morgane Chamboux, Corinne Simon, Frédérique Beau-Salinas, Anaïs Maurier, Marie Sara Agier, Eve Marie Thillard, Bérenger Largeau, Annie Pierre Jonville-Bera |
| 14 |
[GO] |
2023―May―17 |
Only blame SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out |
Josef Finsterer, Fulvio A Scorza |
| 15 |
[GO] |
2023―Mar―07 |
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: the French perspective |
Francesco Salvo, Antoine Pariente, Marie Blanche Valnet-Rabier, Milou-Daniel Drici, Clement Cholle, Clement Mathieu, Allison Singier, Haleh Bagheri, Martine Tebacher, Joelle Micallef, Sophie Gautier |
| 16 |
[GO] |
2023―Mar―07 |
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: a win-win bet with Health Authorities! |
Annie Pierre Jonville-Bera, Sophie Gautier, Joëlle Micallef, Nathalie Massy, Marina Atzenhoffer, Aurélie Grandvuillemin, Milou-Daniel Drici |
| 17 |
[GO] |
2023―Feb―22 |
French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19) |
Claire de Canecaude, François Montastruc, Sandrine Bergeron, Paola Sanchez Pena, Aurélie Grandvuillemin |
| 18 |
[GO] |
2023―Feb―22 |
Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie: comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi? |
Annie Pierre Jonville-Bera, Sophie Gautier, Joëlle Micallef, Nathalie Massy, Marina Atzenhoffer, Milou-Daniel Drici, Aurélie Grandvuillemin |
| 19 |
[GO] |
2023―Feb―16 |
Peripheral facial palsy post SARS-CoV-2 vaccine: a regional pharmacovigilance cases series |
Morgane Chamboux, Corinne Simon, Frédérique Beau-Salinas, Anaïs Maurier, Marie Sara Agier, Eve Marie Thillard, Bérenger Largeau, Annie Pierre Jonville-Bera |
| 20 |
[GO] |
2023―Jan―21 |
Covid-19 Et Vaccins À Adénovirus: Expérience Française De Suivi Renforcé De Pharmacovigilance |
Nathalie Massy, Marina Atzenhoffer, Charlène Boulay, Pauline Pecquet, Fanny Ledys, Jean-Luc Cracowski, Kamel Masmoudi, Marion Lepelley, Valérie Gras Champel |
| 21 |
[GO] |
2023―Jan―20 |
Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines |
Mahmoud Zureik, François Cuenot, Alain Weill, Rosemary Dray-Spira |
| 22 |
[GO] |
2023―Jan―20 |
Impact of coronavirus disease 2019 on contraception use in France |
Noemie Roland, Jerome Drouin, David Desplas, Lise Duranteau, Francois Cuenot, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik |
| 23 |
[GO] |
2023―Jan―20 |
Pharmacovigilance follow-up of patients in the context of the COVID 19 pandemic |
Aurélie Grandvuillemin, Fanny Rocher, Marie Blanche Valnet-Rabier, Milou-Daniel Drici, Anne Dautriche |
| 24 |
[GO] |
2022―Dec―10 |
Impact des confinements sur les hospitalisations survenues dans un contexte d’usage de substances psycho-actives en France selon l’âge pendant la pandémie de COVID-19 |
Justine Perino, Hanta Ramaroson, Nathalie Ong, Julien Bezin, Véronique Gilleron, Amélie Daveluy, Marie Tournier |
| 25 |
[GO] |
2022―Dec―10 |
Chronic spontaneous urticaria following vaccination against SARS-CoV-2 |
Ahmed Zaiem, Yasmine Salem Mahjoubi, Imen Aouinti, Ghozlane Lakhoua, Widd Kaabi, Sarrah Kastalli, Sana Rebii Debbiche, Ons Charfi, Sihem El Aidli |
| 26 |
[GO] |
2022―Dec―10 |
The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions |
Ach Taieb, Euch Mounira El |
| 27 |
[GO] |
2022―Dec―10 |
Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: correspondence |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 28 |
[GO] |
2022―Oct―31 |
Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV2 pandemic |
Pauline Lory, Sandrine Combret, Joelle Michot, Gwenaelle Veyrac, Laurent Chouchana, Aurélie Grandvuillemin |
| 29 |
[GO] |
2022―Oct―06 |
Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine |
Taieb Ach, Fatma Kammoun, Hamza El Fekih, Nassim Ben Haj Slama, Siwar Kahloun, Fatma Ben Fredj, Chédia Laouani, Koussay Ach |
| 30 |
[GO] |
2022―Aug―01 |
Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections |
Zineb Ghrieb, Maud Salmona, David Michonneau, Charles De Saisset, Souhil Allaoua, Jean-Jacques Kiladjian, Jérôme Le Goff, Anne Bergeron, Lina Benajiba |
| 31 |
[GO] |
2022―Jul―13 |
The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans. Effects of the AstraZeneca COVID-19 vaccination |
Rafael Dal-Ré |
| 32 |
[GO] |
2022―Jun―30 |
Hospitalisations après consommation de substances psychoactives pendant la pandémie de Covid-19 |
Claire Dumoulin, Nathalie Ong, Hanta Ramaroson, Louis Létinier, Ghada Miremont-Salamé, Véronique Gilleron, Amélie Daveluy, Justine Perino |
| 33 |
[GO] |
2022―May―19 |
COVID-19: GLOBAL INEQUALITY IN SCIENCE |
Bakthavachalam Elango |
| 34 |
[GO] |
2022―May―07 |
Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic |
Émilien Schultz, Léo Mignot, Jeremy Ward, Daniela Boaventura, Christian Chabannon, Julien Mancini |
| 35 |
[GO] |
2022―Apr―27 |
Adverse drug reactions and ivermectin in COVID-19 |
Jean-Louis Montastruc |
| 36 |
[GO] |
2022―Apr―26 |
Cluster headache after COVID-19 vaccination with Comirnaty: a signal in pharmacovigilance database* |
Michaël Rochoy, Eric Billy, Franck Clarot, Victor Dumortier, Sophie Gautier, Romain Barus |
| 37 |
[GO] |
2022―Apr―20 |
Adverse drug reactions associated with ivermectin use for COVID-19 reported in the WHO’s pharmacovigilance database |
Jeremy T. Campillo, Jean-Luc Faillie |
| 38 |
[GO] |
2022―Apr―20 |
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT) |
Florian Lemaitre, Matthieu Grégoire, Caroline Monchaud, Stéphane Bouchet, Béatrice Saint-Salvi, Elisabeth Polard, Sihem Benaboud, Laurent Chouchana, Jean-Luc Cracowski, Milou-Daniel Drici, Rodolphe Garraffo, Romain Guilhaumou, Annie-Pierre Jonville-Bera, Mathieu Molimard, Patric Muret, Gilles Peytavin, Vincent Richard, Caroline Solas |
| 39 |
[GO] |
2021―Dec―28 |
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic |
Pauline Lory, Jeffrey Lombardi, Clémence Lacroix, Paola Sanchez-Pena, Serena Romani, Aurélie Grandvuillemin |
| 40 |
[GO] |
2021―Dec―04 |
Lessons from the COVID-19 pandemic |
Philippe Lechat |
| 41 |
[GO] |
2021―Oct―25 |
A historical cohort stuy to investigation of statins safety in COVID-19 hospitalized patients |
Saeed Nateghi, Mohammad Mahmoudi Gomari, Hadiseh Hosamirudsari, Behnam Behnoush, Asma Razmjoofard, Goli Azimi, Shokooh Ordookhani, Ali Jafarpour, Neda Faraji |
| 42 |
[GO] |
2021―Oct―08 |
Peptides-based therapeutics: emerging potential therapeutic agents for COVID-19 |
Jagat Narayan Shah, Guang-Qin Guo, Anand Krishnan, Muthusamy Ramesh, Naresh Kumar Katari, Mohd Shahbaaz, Magda H. Abdellattif, Sachin Kumar Singh, Kamal Dua |
| 43 |
[GO] |
2021―Jul―27 |
Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against SARS-CoV-2 and the urgent need of a large immunization in healthcare workers |
Laurent Chouchana, Etienne Canouï, Rui Batista, Adrien Contejean, Alain Cariou, Jean Marc Treluyer, Caroline Charlier |
| 44 |
[GO] |
2021―Jun―01 |
COVID-19 vaccines and pregnancy: what do we know? |
Judith Cottin, Justine Benevent, Sophie Khettar, Isabelle Lacroix |
| 45 |
[GO] |
2021―May―28 |
COVID-19 vaccines: a perspective from social pharmacology |
Jean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, François Montastruc, Haleh Bagheri, Geneviève Durrieu, Agnès Sommet |
| 46 |
[GO] |
2021―May―28 |
COVID-19: Pharmacology has kept the science ship running during the storm |
Mathieu Molimard, Vincent Richard, Jean-Luc Cracowski |
| 47 |
[GO] |
2021―May―12 |
Efficacy of Covid-19 vaccines: from clinical trials to real life |
Dominique Deplanque, Odile Launay |
| 48 |
[GO] |
2021―May―07 |
French organization for the Pharmacovigilance of COVID-19 vaccines: a major challenge |
Clémence Lacroix, Francesco Salvo, Valérie Gras-Champel, Sophie Gautier, Nathalie Massy, Marie-Blanche Valnet-Rabier, Aurélie Grandvuillemin, Céline Mounier, Mehdi Benkebil, Antoine Pariente, Annie-Pierre Jonville-Bera, Joëlle Micallef |
| 49 |
[GO] |
2021―May―07 |
Evaluation of Covid-19 vaccines: pharmacoepidemiological aspects |
Antoine Pariente, Julien Bezin |
| 50 |
[GO] |
2021―Apr―29 |
Eruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19* |
Nihal Bekkali, Tanguy Allard, Eric Estève, Céline Lengellé |
| 51 |
[GO] |
2021―Apr―02 |
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy |
Thomas Soeiro, Francesco Salvo, Antoine Pariente, Aurélie Grandvuillemin, Annie-Pierre Jonville-Béra, Joëlle Micallef |
| 52 |
[GO] |
2021―Mar―06 |
Pneumopathie médicamenteuse ou liée à la COVID-19: un train peut en cacher un autre! |
Mélanie Vasseur, Marine Tambon, Mireille Gony, Nicolas Lebrun, Haleh Bagheri |
| 53 |
[GO] |
2021―Feb―16 |
Un exemple de réorganisation dans le fonctionnement d’un Centre d’investigations cliniques en période de confinement national suite à la pandémie COVID-19 |
Zineb Ghrieb, Souhil Allaoua, Jin Huang, Nathalie Langner, Florène François, Corinne Maréchal, Majdi Jebali, Céleste Lebbé, Abdennour Chellah, Anne Bergeron, Jean-Jacques Kiladjian, Rafael Daltro De Oliveira, Juliette Soret-Dulphy, Lina Benajiba |
| 54 |
[GO] |
2021―Jan―28 |
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19 |
Noël Zahr, Saik Urien, Benoit Llopis, Valérie Pourcher, Olivier Paccoud, Alexandre Bleibtreu, Julien Mayaux, Estelle Gandjbakhch, Guillaume Hekemian, Alain Combes, Olivier Benveniste, David Saadoun, Yves Allenbach, Bruno Pinna, Patrice Cacoub, Christian Funck-Brentano, Joe-Elie Salem |
| 55 |
[GO] |
2021―Jan―20 |
Drug consumption during prolonged lockdown due to Covid-19 as observed in French addiction center |
Mathieu Chappuy, Marie Peyrat, Olivier Lejeune, Nathalie Duvernay, Brigitte David, Philippe Joubert, Philippe Lack |
| 56 |
[GO] |
2021―Jan―19 |
DPP-4 inhibitors and severe course of illness in patients with COVID-19 |
Béatrice Bouhanick, Jean-Luc Cracowski, Jean-Luc Faillie |
| 57 |
[GO] |
2020―Dec―26 |
A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19 |
Chia Siang Kow, Syed Shahzad Hasan |
| 58 |
[GO] |
2020―Nov―01 |
Harnessing immunotherapy to combat COVID-19: A modern snake oil or silver bullet? |
Shivshankar Malkarjun Gunjegaonkar, Thukani Sathanantham Shanmugarajan, Mohanasundaram Arunsundar, Uppuluri Varuna Naga Venkata Arjun, Kadirrel Devi, Sagar Baliram Wankhede, Velayutham Ravichandiran |
| 59 |
[GO] |
2020―Oct―17 |
Modifications pharmacocinétiques liées à une infection aigue. Exemples issus de la pandémie de SARS-Cov2 |
Anaëlle Chavant, Elodie Gautier-Veyret, Stéphanie Chhun, Romain Guilhaumou, Françoise Stanke-Labesque |
| 60 |
[GO] |
2020―Jul―22 |
COVID-19 and NSAIDs: Primum non nocere |
Joëlle Micallef, Thomas Soeiro, Annie-Pierre Jonville Béra |
| 61 |
[GO] |
2020―Jul―12 |
No arguments for extra risk from ibuprofen in SARS-COV2 infection |
Nicholas Moore |
| 62 |
[GO] |
2020―Jun―27 |
NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection |
Medine Cumhur Cure, Adem Kucuk, Erkan Cure |
| 63 |
[GO] |
2020―Jun―27 |
Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: a review |
Lucile Grange, Philippe Guilpain, Marie-Elise Truchetet, Jean-Luc Cracowski |
| 64 |
[GO] |
2020―Jun―23 |
Addictovigilance contribution during COVID-19 epidemic and lockdown in France |
Maryse Lapeyre-Mestre, Alexandra Boucher, Amelie Daveluy, Valerie Gibaja, Emilie Jouanjus, Michel Mallaret, Helene Peyrière, Joëlle Micallef |
| 65 |
[GO] |
2020―Jun―06 |
Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic |
Jean-Luc Cracowski, Mathieu Molimard, Vincent Richard |
| 66 |
[GO] |
2020―May―23 |
Chloroquine and hydroxychloroquine in the management of COVID-19: much kerfuffle but little evidence |
Matthieu Roustit, Romain Guilhaumou, Mathieu Molimard, Milou Drici, Silvy Laporte, Jean-Louis Montastruc |
| 67 |
[GO] |
2020―May―20 |
Renin-angiotensin-aldosterone system and COVID-19 infection |
Joachim Alexandre, Jean-Luc Cracowski, Vincent Richard, Béatrice Bouhanick |
| 68 |
[GO] |
2020―May―15 |
Diabetes and COVID-19 |
Béatrice Bouhanick, Jean Luc Cracowski, Jean Luc Faillie |
| 69 |
[GO] |
2020―May―15 |
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France |
François Montastruc, Charles Romano, Jean-Louis Montastruc, Stein Silva, Thierry Seguin, Vincent Minville, Bernard Georges, Béatrice Riu-Poulenc, Olivier Fourcade |
| 70 |
[GO] |
2020―May―07 |
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection |
Joëlle Micallef, Thomas Soeiro, Jonville-Béra Annie-Pierre |
| 71 |
[GO] |
2020―May―07 |
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: a survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers |
Alexandre Gérard, Serena Romani, Audrey Fresse, Delphine Viard, Nadège Parassol, Aurélie Granvuillemin, Laurent Chouchana, Fanny Rocher, Milou-Daniel Drici |
| 72 |
[GO] |
2020―May―05 |
Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data |
Aurélie Grandvuillemin, Audrey Fresse, Clément Cholle, Samir Yamani, Anne Dautriche |
